King’s College London spinout Algocyte has developed a new portable blood testing device which monitors patient health at home.
Algocyte has brought together expertise in artificial intelligence, bioengineering, computational biology and clinical medicine to build a device that connects via Bluetooth and uses AI to build a picture of an individual’s health over time.
The tool could be beneficial for patients who require regular monitoring, such as those undergoing chemotherapy, who currently rely on frequent hospital or GP visits for blood tests.
Patients collect small blood samples through minimally invasive methods such as finger pricking and place them into the device.
The sensors measure properties of the blood sample, which are analysed using AI algorithms to generate blood test results that can be shared digitally with doctors and patients on the spot.
While most blood tests provide only a snapshot of a person's health at a single moment in time, this technology helps identify small changes in an individual's health over time.
The technology could also free up resources for the NHS, with millions of blood tests are carried out in the UK every year, helping doctors diagnose disease, monitor treatments and assess overall health.
The device has achieved UK Conformity Assessed (UKCA) regulatory mark as it complies with all relevant health, safety, and environmental protection standards.
Further testing and evaluation is in progress ahead of its commercial deployment.
Algocyte is continuing to gather scientific evidence and complete further regulatory steps as it works towards making the technology available more widely in different settings and for predictive purposes.
